Celltrion Healthcare (Formerly Known As Celltrion)
1000 Marina Boulevard
About Celltrion Healthcare (Formerly Known As Celltrion)Celltrion Healthcare conducts the worldwide marketing, sales and distribution of biological medicines developed by Celltrion, Inc. through an extensive global network that spans more than 120 different countries. Celltrion Healthcare’s products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the US Food and Drug Administration (FDA) cGMP guidelines and the EU GMP guidelines.
CEO: Jung Jini
Please click here for clinical trial information.
Tweets by Celltrion
78 articles with Celltrion Healthcare (Formerly Known As Celltrion)
Celltrion, Inc.: No Difference In Efficacy Or Immunogenicity Following Switch To Remsima®? (Infliximab) From Originator
Celltrion, Inc. Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets
Celltrion Healthcare: Data Show The World’s First European Medicines Agency-Approved Biosimilar Monoclonal Antibody Remsima Could Reduce Cost Of Treating Crohn’s Disease By Up To €336 Million Over Five Years
Celltrion, Inc.: Experts Share Their “Real World” Experience Of Treating People With Inflammatory Bowel Disease (IBD) With Biosimilar Anti-Tnfa Monoclonal Antibody (Mab)
Celltrion, Inc.: Successful Development of Broad Spectrum Human Monoclonal Antibodies Against Major Influenza Viruses (H1N1 and H5N1)
Hospira, Inc., Celltrion, Inc. Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
Celltrion, Inc. and CSL Limited Announce Collaboration to Develop and Manufacture Monoclonal Antibody
A&G Pharmaceutical, Inc. And Celltrion, Inc. Announce Bioprocess Development & Manufacturing Agreement For A&G Anti-GP88 Cancer Therapeutic Antibody - Deal Worth Up To $8.4 Million
VaxGen, Inc. Advances Toward Filing Its Financial Statements As Celltrion, Inc. Completes Preparation Of U.S. GAAP Financial Statements
Aphton Corporation Announces Closing of Commercialization and Manufacturing Agreements for IGN311 With Celltrion, Inc.